Randomness Drives Tumour Cells Response To Chemotherapy
A new weapon in the arsenal of cancer cells' treatment resistance, according to a study conducted by the Garvan Institute of Medical Research, is...
Animal Testing Could See An End With An Artificial Model
Uppsala University researchers have created an artificial blood-brain barrier model that can be used to assess the efficacy of anti-body-based medicines while reducing animal...
Germany Rolls First CAR-T Push For Muscle Inflammation Cure
One of the university hospitals in Germany was the first in the world to effectively treat a patient with a severe case of muscular...
DNA Mutations Can Help Kidney Cancer Recurrence Be Assessed
One of the international studies on kidney cancer recurrence has found that physicians can forecast the likelihood of a disease returning by way of...
New Initiatives To Boost Biomanufacturing In South Australia
Biomanufacturing industry is all set to get the much-needed push by the recent South Australian Government’s announcement when it comes to new initiatives as...
Acute Leukaemia Can Be Averted By Foetal Development Protein
A protein present in foetal development has been zeroed upon by the researchers that has a strong prophylactic effect versus acute myeloid leukaemia- AML.
Right...
Cancer Vaccine Transformation – A Possibility Soon To Occur
Researchers at Northwestern University's International Institute for Nanotechnology (IIN) have devised a novel method for dramatically increasing the potency of practically any vaccine. The...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...